NCT03579589View on ClinicalTrials.gov

The Effect of Sugammadex Versus Neostigmine During Neuromuscular Blockade Reversal

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 15, 2018

Primary Completion Date

December 15, 2019

Study Completion Date

December 15, 2019

Conditions
Neuromuscular Blockade
Interventions
DRUG

Sugammadex vs Neostigmine

Patients will be randomized into either Sugammadex or Neostigmine neuromuscular blockade reversal.

Trial Locations (1)

43210

The Ohio State University Wexner Medical Center, Columbus

All Listed Sponsors
lead

Ohio State University

OTHER

NCT03579589 - The Effect of Sugammadex Versus Neostigmine During Neuromuscular Blockade Reversal | Biotech Hunter | Biotech Hunter